Viemed Healthcare (VMD) Current Deferred Revenue (2018 - 2026)

Viemed Healthcare's Current Deferred Revenue history runs 9 years deep, the most recent figure standing at $7.5 million for Q1 2026.

• Quarterly Current Deferred Revenue rose 10.07% year-over-year to $7.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.5 million (up 10.07% YoY) and the FY2025 annual result came in at $7.5 million, up 12.34% from the prior year.
• Current Deferred Revenue was $7.5 million for Q1 2026 at Viemed Healthcare, down from $7.5 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $7.8 million in Q3 2025 and bottomed at $3.9 million in Q1 2022.
• A 5-year average of $6.1 million and a median of $6.5 million in 2023 frame the typical range for Current Deferred Revenue.
• Annual changes were most pronounced in 2023 — Current Deferred Revenue surged 35.39% — and 2025, when it increased 6.99%.
• Viemed Healthcare's Current Deferred Revenue stood at $4.6 million in 2022, then jumped by 34.23% to $6.2 million in 2023, then gained by 7.85% to $6.7 million in 2024, then climbed by 12.34% to $7.5 million in 2025, then dropped by 0.55% to $7.5 million in 2026.
• Business Quant data shows VMD's Current Deferred Revenue at $7.5 million in Q1 2026, $7.5 million in Q4 2025, and $7.8 million in Q3 2025.